Skip to main content

Thomas Walsh

Analyst

Barclays

Equibles does not estimate personal net worth.

About Thomas Walsh

Thomas Walsh is recorded as Analyst at Barclays. Thomas Walsh has spoken on 4 earnings calls across 4 companies, most recently for Lumexa Imaging Holdings, Inc. on November 10, 2026. Those appearances were for Lumexa Imaging Holdings, Inc. (LMRI), Surgery Partners, Inc. (SGRY), Acadia Healthcare Company, Inc. (ACHC) and Tenet Healthcare Corp (THC). The companies whose calls Thomas Walsh spoke on are classified in the Healthcare sector.

Thomas Walsh on recent calls

“Can you share the same center system-wide revenue per scan growth in the quarter and comment on pricing, commercial pair mix, and collections relative to your expectations?”
Analyst — Barclays, Lumexa Imaging 3Q’26 Earnings Call ·
“You shared some of the deliberate actions taken to address payer mix pressures from the back half of 2025. How did commercial mix come in in the quarter? And could you comment more broadly on the view of the strength of the consumer wallet and employment trends in your markets?”
Analyst — Barclays, Surgery Partners, Inc. Q1 FY2026 Earnings Call ·
“The core EBITDA growth in the bridge seems to outpace the underlying components of rate and volume. Can you help us understand what else is contributing to the six to seven percent core growth potentially on the cost side?”
Analyst — Barclays, Acadia Healthcare Company, Inc. Q4 FY2025 Earnings Call ·
“With Conifer's services to Common Spirit concluding at the end of this year, Could you frame the current plan to redeploy existing resources to growth opportunities and otherwise reduce expenses to right-size the cost structure?”
Analyst — Barclays, Tenet Healthcare Corp Q4 FY2025 Earnings Call ·

Affiliation history

  • Barclays

    Analyst

    Source not stated

    Current

Company network

Recent activity